SHIFTBIO’s CSO
Contract science organization

 End-to-end partner
of EV drug development

SHIFTBIO enables the loading of a wide range of therapeutics onto EVs. 

We provide a new type of drug development service.

We developed EV Sorting Motif
by identifying specific amino
acid sequence that effectively

traffic drug targets to EVs.

ESM is a powerful platform
technology that surpasses existing
EV engineering technology. 


The key to SHIFTBIO's EV therapy
development is the technology
for loading drug targets.

Through our optimized EV therapy
development strategy,

we can expedite the new drug
development process.

Collaborative research


SHIFTBIO can verify promising early
drug candidates from partners and
apply ESM platform technology.

Based on an optimized EV therapeutics development strategy, 
we provide the essential elements
for each milestone and jointly advance
the development of novel therapeutics.

SHIFTBIO's AI-driven ESM platform
technology is a technique
for predicting the efficiency
of loading therapeutics within EVs
and the therapeutic efficacy
of the payloads.

Optimizing the 
structure of cargo and ESM for enhanced
loading efficiency

Predicting
cargo-receptor
binding affinity for
efficient drug
screening

Our AI-driven ESM platform
technology significantly reduces
the time and cost required to
identifying EV drug candidates.

EV Sorting Motif (ESM)

SHIFTBIO enables the loading of a wide range of therapeutics onto EVs. 

We provide a new type of drug development service.

ESM is a powerful platform technology
that surpasses existing EV engineering technology. 


SHIFTBIO Drug Development Process 

The key to SHIFTBIO's EV therapy development is the technology for loading drug targets.

Through our optimized EV therapy development strategy,

we can expedite the new drug development process.